Throdahl Mark C 4
4 · ORTHOPEDIATRICS CORP · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Orthopediatrics (KIDS) Director Mark Throdahl Receives Award
What Happened
Mark C. Throdahl, a director of Orthopediatrics Corp. (KIDS), was granted 11,436 shares on 2026-06-09 as an award/acquisition (transaction code A). The grant is reported at $0.00 per share (total reported value $0), consistent with a restricted stock award rather than a market purchase.
Key Details
- Transaction date: 2026-06-09; Form 4 filed: 2026-06-10 (timely filing).
- Price: $0.00 per share; total reported value $0.
- Shares involved: 11,436 shares granted.
- Shares owned after transaction: Not disclosed in the provided excerpt.
- Footnote: F1 notes restricted stock awards totaling 38,660 shares (the filing indicates restricted awards but does not further detail vesting here).
- Filing timeliness: Filed within one business day of the transaction (not late).
Context
Restricted stock awards are typically compensation that vests over time and are not immediate cash sales; a $0 grant price is common for such awards. Awards are different from open-market purchases or sales and do not directly signal an immediate change in trading behavior.
Insider Transaction Report
Form 4
Throdahl Mark C
Director
Transactions
- Award
Common Stock
[F1]2026-06-09+11,436→ 179,317 total
Holdings
- 22,497(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Includes restricted stock awards totaling 38,660 shares.
Signature
/s/ Daniel J. Gerritzen, Attorney-in-Fact|2026-06-10